You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung carcinoma (NSCLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Observing Palliative Asymptomatic Centrally Located Advanced

Active, not recruiting
  • Non-small Cell Lung Carcinoma
  • None: Questionnaire Study
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 6, 2022

Lung Cancer Trial (ortataxel)

Completed
  • Lung Cancer
  • (no location specified)
Sep 23, 2022

NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Wuhan, Hubei, China
    Qian Chu
Aug 18, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

Not yet recruiting
  • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
  • (no location specified)
Aug 27, 2023

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • BAI combine with DEB-BACE
  • Zhengzhou, Henan, China
    Gang Wu
Nov 7, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    NSCLC Trial (JDQ443)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Feb 2, 2023

    Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
    • New York, New York
      NYU Langone Health
    Apr 4, 2023

    Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

    Not yet recruiting
    • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
    • New York, New York
      NYU Langone Health
    Apr 4, 2023

    NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Iowa City, Iowa
      University of Iowa
    Oct 10, 2023

    Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Jinan, Shandong, China
      Shandong Cancer Hospital and Institute
    Aug 8, 2023

    NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
    • tereotactic body radiotherapy
    • (no location specified)
    Dec 1, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Nov 7, 2023

    NSCLC Trial in Suzhou (Envafolimab Injection)

    Recruiting
    • NSCLC
    • Envafolimab Injection
    • Suzhou, Jiangsu, China
      Northern Jiangsu People's Hospital
    Oct 29, 2023

    ALK Positive NSCLC Trial in Guangzhou (Loratinib)

    Recruiting
    • ALK Positive Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial Perople's Hospital
    Oct 19, 2023

    NSCLC Trial (Sutetinib Maleate Capsule)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Sutetinib Maleate Capsule
    • (no location specified)
    Aug 18, 2023

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      NSCLC Trial (KB-GDT-01)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • KB-GDT-01
      • (no location specified)
      Sep 29, 2023